Clincosm LogoSign in Get a demo

HPV and Male Homosexuality in General Practice?

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT05078554
Collaborator
(none)
15
Enrollment
1
Location
8.2
Anticipated Duration (Months)
1.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination.

The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    15 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?
    Actual Study Start Date :
    May 27, 2021
    Anticipated Primary Completion Date :
    Feb 1, 2022
    Anticipated Study Completion Date :
    Feb 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace? [Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 26 Years
    Sexes Eligible for Study:
    Male
    Inclusion criteria:

    • Age: 18-26 years

    • Consultation at the HUS Cegidd as part of an STI screening

    • Subject who expressed no opposition to participating in the study

    Exclusion criteria:

    • Refusal of the patient to participate in the study

    • Subject who had already benefited from HPV vaccination (at least one dose)

    • Inability to give informed consent

    • Subject under safeguarde of justice

    • Subject under guardianship or under curatorship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service du Trait d'Union - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05078554
    Other Study ID Numbers:
    • 8048
    First Posted:
    Oct 14, 2021
    Last Update Posted:
    Nov 3, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Papilloma Viral Infection
    HPV
    HPV vaccine
    Additional relevant MeSH terms:
    Virus Diseases
    Papillomavirus Infections
    Papilloma

    Study Results

    No Results Posted as of Nov 3, 2021